{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:39Z","timestamp":1793089119061,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Innovative Research Award"],"award-info":[{"award-number":["Innovative Research Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The objective of this work was to describe magnetic resonance imaging (MRI) changes over time in inflammatory and structural lesions at the sacroiliac joint (SIJ) in children with spondyloarthritis (SpA) exposed and unexposed to tumor necrosis factor inhibitor (TNFi).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective, multicenter study of SpA patients with suspected or confirmed sacroiliitis who underwent at \u22652 pelvic MRI scans. Images were reviewed independently by 3 radiologists and scored for inflammatory and structural changes using the Spondyloarthritis Research Consortium of Canada (SPARCC) SIJ inflammation score (SIS) and structural score (SSS). Longitudinal, quantitative changes in patient MRI scans were measured using descriptive statistics and stratified by TNFi exposure. We used an average treatment effects (ATE) regression model to explore the average effect of TNFi exposure over time on inflammatory and structural lesions, adjusting for baseline lesion scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-six subjects were evaluated using the SIS (<jats:italic>n<\/jats:italic>\u00a0=\u200945) and SSS (<jats:italic>n<\/jats:italic>\u00a0=\u200918). Median age at baseline imaging was 13.6\u2009years, 63% were male and 71% were white. Twenty-three subjects (50%) were TNFi exposed between MRI studies. The median change in SIS in TNFi exposed and unexposed subjects with a baseline SIS \u22650 was \u2212\u200920.7 and\u2009\u2212\u200914.3, respectively (<jats:italic>p<\/jats:italic>\u00a0=\u20090.09). Eleven (85%) TNFi exposed and 8 (89%) unexposed subjects with a baseline SIS \u22650 met the SIS minimal clinically important difference (MCID; \u22652.5). Using the ATE model adjusted for baseline SIS, the average effect of TNFi on SIS in patients with a baseline SIS \u22652 was \u2212\u200914.5 (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.01). Unadjusted erosion change score was significantly worse in TNFi unexposed versus exposed subjects (<jats:italic>p<\/jats:italic>\u00a0=\u20090.03) but in the ATE model the effect of TNFi was not significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study quantitatively describes how lesions in the SIJs on MRI change over time in patients exposed to TNFi versus unexposed. Follow-up imaging in TNFi exposed patients showed greater improvement than the unexposed group by most metrics, some of which reached statistical significance. Surprisingly, a majority of TNFi unexposed children with a baseline SIS\u22652 met the SIS MCID. Additional studies assessing the short and long-term effects of TNFi on inflammatory and structural changes in juvenile SpA are needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-021-00647-6","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:03:30Z","timestamp":1638446610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor"],"prefix":"10.1186","volume":"19","author":[{"given":"Timothy G.","family":"Brandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary G.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Biko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dax G.","family":"Rumsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-0443","authenticated-orcid":false,"given":"Pamela F.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"11","key":"647_CR1","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3899\/jrheum.100090","volume":"37","author":"I Pagnini","year":"2010","unstructured":"Pagnini I, Savelli S, Matucci-Cerinic M, Fonda C, Cimaz R, Simonini G. Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. J Rheumatol. 2010;37(11):2395\u2013401. https:\/\/doi.org\/10.3899\/jrheum.100090.","journal-title":"J Rheumatol"},{"issue":"11","key":"647_CR2","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1002\/art.22181","volume":"54","author":"B Flato","year":"2006","unstructured":"Flato B, Hoffmann-Vold AM, Reiff A, Forre O, Lien G, Vinje O. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum. 2006;54(11):3573\u201382. https:\/\/doi.org\/10.1002\/art.22181.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"647_CR3","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3899\/jrheum.100014","volume":"37","author":"ML Stoll","year":"2010","unstructured":"Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J Rheumatol. 2010;37(11):2402\u20138. https:\/\/doi.org\/10.3899\/jrheum.100014.","journal-title":"J Rheumatol"},{"issue":"11","key":"647_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s002560050446","volume":"27","author":"M Bollow","year":"1998","unstructured":"Bollow M, Braun J, Biedermann T, Mutze S, Paris S, Schauer-Petrowskaja C, et al. Use of contrast-enhanced MR imaging to detect sacroiliitis in children. Skelet Radiol. 1998;27(11):606\u201316. https:\/\/doi.org\/10.1007\/s002560050446.","journal-title":"Skelet Radiol"},{"issue":"3","key":"647_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/art.21174","volume":"53","author":"M Stone","year":"2005","unstructured":"Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum. 2005;53(3):445\u201351. https:\/\/doi.org\/10.1002\/art.21174.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"647_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3899\/jrheum.111031","volume":"39","author":"HA Chen","year":"2012","unstructured":"Chen HA, Chen CH, Liao HT, Lin YJ, Chen PC, Chen WS, et al. Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol. 2012;39(5):1013\u20138. https:\/\/doi.org\/10.3899\/jrheum.111031.","journal-title":"J Rheumatol"},{"issue":"5","key":"647_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/acr.22500","volume":"67","author":"DR Jadon","year":"2015","unstructured":"Jadon DR, Shaddick G, Jobling A, Ramanan AV, Sengupta R. Clinical outcomes and progression to orthopedic surgery in juvenile- versus adult-onset ankylosing spondylitis. Arthritis Care Res (Hoboken). 2015;67(5):651\u20137. https:\/\/doi.org\/10.1002\/acr.22500.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"11","key":"647_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1726-4901(09)70432-0","volume":"72","author":"YC Lin","year":"2009","unstructured":"Lin YC, Liang TH, Chen WS, Lin HY. Differences between juvenile-onset ankylosing spondylitis and adult-onset ankylosing spondylitis. Journal of the Chinese Medical Association : JCMA. 2009;72(11):573\u201380. https:\/\/doi.org\/10.1016\/S1726-4901(09)70432-0.","journal-title":"Journal of the Chinese Medical Association : JCMA"},{"issue":"2","key":"647_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/ard.2007.072512","volume":"67","author":"LS Gensler","year":"2008","unstructured":"Gensler LS, Ward MM, Reveille JD, Learch TJ, Weisman MH, Davis JC Jr. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis. 2008;67(2):233\u20137. https:\/\/doi.org\/10.1136\/ard.2007.072512.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"647_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/acr.22665","volume":"68","author":"PF Weiss","year":"2016","unstructured":"Weiss PF, Xiao R, Biko DM, Chauvin NA. Assessment of Sacroiliitis at diagnosis of juvenile Spondyloarthritis by radiography, magnetic resonance imaging, and clinical examination. Arthritis Care Res (Hoboken). 2016;68(2):187\u201394. https:\/\/doi.org\/10.1002\/acr.22665.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"647_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/ard.2008.092304","volume":"68","author":"FD O'Shea","year":"2009","unstructured":"O'Shea FD, Boyle E, Riarh R, Tse SM, Laxer RM, Inman RD. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis. 2009;68(9):1407\u201312. https:\/\/doi.org\/10.1136\/ard.2008.092304.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"647_CR12","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1002\/art.39257","volume":"67","author":"J Sieper","year":"2015","unstructured":"Sieper J, van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, et al. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous Golimumab in patients with active nonradiographic axial Spondyloarthritis. Arthritis Rheumatol. 2015;67(10):2702\u201312. https:\/\/doi.org\/10.1002\/art.39257.","journal-title":"Arthritis Rheumatol."},{"key":"647_CR13","doi-asserted-by":"crossref","unstructured":"Pedersen SJ, Poddubnyy D, S\u00f8rensen IJ, Loft A-GG, Hindrup JS, Thamsborg G, et al. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods. Arthritis & rheumatology (Hoboken, NJ). 2016;68(2):418\u201329.","DOI":"10.1002\/art.39434"},{"issue":"7","key":"647_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/annrheumdis-2015-207596","volume":"75","author":"WP Maksymowych","year":"2016","unstructured":"Maksymowych WP, Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, et al. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Ann Rheum Dis. 2016;75(7):1328\u201335. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207596.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"647_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/art.40750","volume":"71","author":"TJP Bray","year":"2019","unstructured":"Bray TJP, Lopes A, Fisher C, Ciurtin C, Sen D, Hall-Craggs MA. Sacroiliac joint Ankylosis in young Spondyloarthritis patients receiving biologic therapy: observation of serial magnetic resonance imaging scans. Arthritis Rheumatol. 2019;71(4):594\u20138. https:\/\/doi.org\/10.1002\/art.40750.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"647_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-018-1642-8","volume":"20","author":"PF Weiss","year":"2018","unstructured":"Weiss PF, Xiao R, Brandon TG, Biko DM, Maksymowych WP, Lambert RG, et al. Radiographs in screening for sacroiliitis in children: what is the value? Arthritis research & therapy. 2018;20(1):141. https:\/\/doi.org\/10.1186\/s13075-018-1642-8.","journal-title":"Arthritis research & therapy"},{"issue":"8","key":"647_CR17","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3899\/jrheum.120131","volume":"39","author":"WP Maksymowych","year":"2012","unstructured":"Maksymowych WP, Lambert RG, Brown LS, Pangan AL. Defining the minimally important change for the SpondyloArthritis research consortium of Canada spine and sacroiliac joint magnetic resonance imaging indices for ankylosing spondylitis. J Rheumatol. 2012;39(8):1666\u201374. https:\/\/doi.org\/10.3899\/jrheum.120131.","journal-title":"J Rheumatol"},{"issue":"1","key":"647_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/annrheumdis-2017-211605","volume":"77","author":"WP Maksymowych","year":"2017","unstructured":"Maksymowych WP, Wichuk S, Dougados M, Jones HE, Pedersen R, Szumski A, et al. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis. Ann Rheum Dis. 2017;77(1):78\u201384. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211605.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"647_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3899\/jrheum.140519","volume":"42","author":"WP Maksymowych","year":"2015","unstructured":"Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score. J Rheumatol. 2015;42(1):79\u201386. https:\/\/doi.org\/10.3899\/jrheum.140519.","journal-title":"J Rheumatol"},{"issue":"10","key":"647_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3899\/jrheum.171329","volume":"45","author":"PF Weiss","year":"2018","unstructured":"Weiss PF, Maksymowych WP, Lambert RG, Jaremko JL, Biko DM, Paschke J, et al. Feasibility and reliability of the Spondyloarthritis research consortium of Canada sacroiliac joint structural score in children. J Rheumatol. 2018;45(10):1411\u20137. https:\/\/doi.org\/10.3899\/jrheum.171329.","journal-title":"J Rheumatol"},{"issue":"1","key":"647_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13075-018-1543-x","volume":"20","author":"PF Weiss","year":"2018","unstructured":"Weiss PF, Maksymowych WP, Lambert RG, Jaremko JL, Biko DM, Paschke J, et al. Feasibility and reliability of the Spondyloarthritis research consortium of Canada sacroiliac joint inflammation score in children. Arthritis Research & Therapy. 2018;20(1):56. https:\/\/doi.org\/10.1186\/s13075-018-1543-x.","journal-title":"Arthritis Research & Therapy."},{"issue":"1","key":"647_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-020-02157-4","volume":"22","author":"PF Weiss","year":"2020","unstructured":"Weiss PF, Maksymowych WP, Xiao R, Biko DM, Francavilla ML, Lambert RG, et al. Spondyloarthritis research consortium of Canada sacroiliac joint inflammation and structural scores: change score reliability and recalibration utility in children. Arthritis Res Ther. 2020;22(1):58. https:\/\/doi.org\/10.1186\/s13075-020-02157-4.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"647_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3899\/jrheum.140806","volume":"42","author":"R van den Berg","year":"2015","unstructured":"van den Berg R, de Hooge M, Bakker PA, van Gaalen F, Navarro-Compan V, Fagerli KM, et al. Metric properties of the SPARCC score of the sacroiliac joints - data from baseline, 3-month, and 12-month Followup in the SPACE cohort. J Rheumatol. 2015;42(7):1186\u201393. https:\/\/doi.org\/10.3899\/jrheum.140806.","journal-title":"J Rheumatol"},{"key":"647_CR24","unstructured":"B R. Fundamentals of Biostatistics. Belmont, CA: Tomson-Brooks\/Cole; 2006."},{"issue":"10","key":"647_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","volume":"71","author":"F Kroon","year":"2012","unstructured":"Kroon F, Landew\u00e9 R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71(10):1623\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201370.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"647_CR26","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Heijde D, Landew\u00e9 R, B\u00e9hier JM, Calin A, Olivieri I, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756\u201365. https:\/\/doi.org\/10.1002\/art.21054.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"647_CR27","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","volume":"75","author":"J Sieper","year":"2016","unstructured":"Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, et al. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis. 2016;75(8):1438\u201343. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207897.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"647_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Rheumatol. 2019;71(6):846\u201363. https:\/\/doi.org\/10.1002\/art.40884.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"647_CR29","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/art.38738","volume":"66","author":"R van den Berg","year":"2014","unstructured":"van den Berg R, Lenczner G, Feydy A, van der Heijde D, Reijnierse M, Saraux A, et al. Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort. Arthritis Rheumatol. 2014;66(9):2403\u201311. https:\/\/doi.org\/10.1002\/art.38738.","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"647_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/BOR.0b013e328352b7bd","volume":"24","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Sieper J. Radiographic progression in ankylosing spondylitis\/axial spondyloarthritis: how fast and how clinically meaningful? Curr Opin Rheumatol. 2012;24(4):363\u20139. https:\/\/doi.org\/10.1097\/BOR.0b013e328352b7bd.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"647_CR31","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65(10):2645\u201354. https:\/\/doi.org\/10.1002\/art.38070.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"647_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.39434","volume":"68","author":"SJ Pedersen","year":"2015","unstructured":"Pedersen SJ, Poddubnyy D, Sorensen IJ, Loft AG, Hindrup JS, Thamsborg G, et al. Course of MRI inflammation and structural lesions in the sacroiliac joints in a randomized double-blind placebo-controlled trial of adalimumab in patients with axial Spondyloarthritis as assessed by the Berlin and SPARCC methods (the DANISH study). Arthritis Rheumatol. 2015;68(2):418\u201329. https:\/\/doi.org\/10.1002\/art.39434.","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"647_CR33","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1002\/art.23044","volume":"56","author":"RG Lambert","year":"2007","unstructured":"Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007;56(12):4005\u201314. https:\/\/doi.org\/10.1002\/art.23044.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"647_CR34","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Deodhar A, Wei JC, Drescher E, Fleishaker D, Hendrikx T, et al. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2017;76(8):1340\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210322.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-021-00647-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:09:03Z","timestamp":1638446943000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00647-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00647-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study\u2019s protocol was reviewed and approved by the University of Alabama at Birmingham\u2019s (IRB-160701011) and Children\u2019s Hospital of Philadelphia\u2019s (IRB 16\u2013013015) Committees for the Protection of Human Subjects and the ethics committee at the University of Alberta (REB Pro00081651). Waivers of consent and HIPAA authorization were granted as procedures represented minimal risk to the subjects and did not adversely affect the rights and welfare of the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Weiss has served as a consultant for Lilly and Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}